nitrendipine has been researched along with Asthma in 4 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nitrendipine was given to eight patients with chronic stable asthma prior to a histamine challenge study and compared in a double-blind cross-over fashion with placebo." | 9.06 | Nitrendipine therapy in asthmatic subjects. ( Cormie, P; Harvey, J; Marley, JE; Mulloy, EM, 1990) |
| "Felodipine is a new calcium antagonist of the dihydropyridine group with a high selectivity for arteriolar smooth muscle; it is under clinical investigation for the treatment of hypertension." | 6.66 | Felodipine, a new calcium antagonist, modifies exercise-induced asthma. ( Patel, KR; Peers, E, 1988) |
| "Nitrendipine was given to eight patients with chronic stable asthma prior to a histamine challenge study and compared in a double-blind cross-over fashion with placebo." | 5.06 | Nitrendipine therapy in asthmatic subjects. ( Cormie, P; Harvey, J; Marley, JE; Mulloy, EM, 1990) |
| "Felodipine is a new calcium antagonist of the dihydropyridine group with a high selectivity for arteriolar smooth muscle; it is under clinical investigation for the treatment of hypertension." | 2.66 | Felodipine, a new calcium antagonist, modifies exercise-induced asthma. ( Patel, KR; Peers, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG | 1 |
| Preti, D | 1 |
| Materazzi, S | 1 |
| Geppetti, P | 1 |
| Sweeney, D | 1 |
| Hollins, F | 1 |
| Gomez, E | 1 |
| Saunders, R | 1 |
| Challiss, RA | 1 |
| Brightling, CE | 1 |
| Mulloy, EM | 1 |
| Cormie, P | 1 |
| Harvey, J | 1 |
| Marley, JE | 1 |
| Patel, KR | 1 |
| Peers, E | 1 |
1 review available for nitrendipine and Asthma
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Pe | 2010 |
2 trials available for nitrendipine and Asthma
| Article | Year |
|---|---|
Nitrendipine therapy in asthmatic subjects.
Topics: Adult; Asthma; Double-Blind Method; Female; Histamine; Humans; Hypertension; Male; Maximal Expirator | 1990 |
Felodipine, a new calcium antagonist, modifies exercise-induced asthma.
Topics: Adult; Asthma; Asthma, Exercise-Induced; Blood Pressure; Calcium Channel Blockers; Felodipine; Femal | 1988 |
1 other study available for nitrendipine and Asthma
| Article | Year |
|---|---|
[Ca2+]i oscillations in ASM: relationship with persistent airflow obstruction in asthma.
Topics: Adult; Aged; Asthma; Biopsy; Caffeine; Calcium Signaling; Case-Control Studies; Female; Forced Expir | 2014 |